Survival: ?
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Doxil
Country: United States
City/State/Province: Minneapolis, Minnesota
Hospital: University of Minnesota Medical School
Journal: Link
Date: 1/2002


Patients: This Phase II study involved 15 patients with mesothelioma.

Treatment: The treatment consisted of the administration of the drug, doxorubicin (doxil). 

Toxicity: Toxicities included neutrophils (grade 3 and 4), skin (grade 1 and 2), mucositis (grade 1 and 2), nausea (grade 1), and fatigue (grade 1). 

Results: One patient had a partial response. Overall survival was not discussed.